SHG:688399 - Jiangsu Bioperfectus Technologies Co Ltd

Jiangsu Bioperfectus Technolog
Sector: Health Care, Industry: Biotechnology

Add to Watchlist

•  Default
• New Watchlist

   

Yahoo Finance

• Summary
• Financials
• Dividend
• Prices
• Posts
• User
• Alerts

Balance Sheet Cash Flow Income Statement Key Ratios Personalized

Show %	2018 Q3	2018 Q4	2019 Q1	2019 Q2	2019 Q3	2019 Q4	2020 Q1	2020 Q2	2020 Q3	2020 Q4	2021 Q1	2021 Q2	2021 Q3	2021 Q4	2022 Q1	2022 Q2	2022 Q3	2022 Q4	2023 Q1	2023 Q2	2023 Q3	2023 Q4	2024 Q1	Graph
Total Revenue	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	274.05M -68.0%	1.04B 280.0%	667.17M -35.9%	1.52B 128.1%	1.74B 14.6%	1.03B -41.1%	1.24B 20.8%	94.05M -92.4%	92.56M -1.6%	89.82M -3.0%	126.75M 41.1%	91.12M -28.1%
Cost of Revenue	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	70.9M -68.6%	315.22M 344.6%	264.26M -16.2%	550.34M 108.3%	743.2M 35.0%	395.38M -46.8%	490.91M 24.2%	32.73M -93.3%	33.08M 1.1%	44.42M 34.3%	35.27M -20.6%	26.49M -24.9%
Gross Profit	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	203.14M -67.8%	726.09M 257.4%	402.91M -44.5%	971.56M 141.1%	1B 3.0%	632.18M -36.8%	750.39M 18.7%	61.33M -91.8%	59.48M -3.0%	45.4M -23.7%	91.48M 101.5%	64.63M -29.3%
Total Expenses	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	156.86M -60.4%	455.42M 190.3%	472.7M 3.8%	772.23M 63.4%	1.03B 33.0%	542.83M -47.1%	732.56M 35.0%	116.46M -84.1%	130.15M 11.8%	182.96M 40.6%	188.12M 2.8%	62.06M -67.0%
Operating Expense	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	85.96M -49.5%	140.2M 63.1%	208.44M 48.7%	221.88M 6.4%	283.59M 27.8%	147.46M -48.0%	241.65M 63.9%	83.73M -65.4%	97.07M 15.9%	138.53M 42.7%	152.85M 10.3%	35.57M -76.7%
Operating Income	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	117.18M -74.5%	585.89M 400.0%	194.47M -66.8%	749.67M 285.5%	717.24M -4.3%	484.72M -32.4%	508.74M 5.0%	-22.4M -	-37.59M -	-93.14M -	-61.37M -	29.06M -
Net Income (Cont Operations)	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	502.03M -	-	-	-	1.23B -	-	-	-	-68.29M -	-	-	-
Net Income	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	114.65M -70.4%	494.12M 331.0%	197.06M -60.1%	631.07M 220.2%	602.46M -4.5%	390.82M -35.1%	203.55M -47.9%	-19.42M -	-48.87M -	-107.72M -	-197.8M -	40.07M -
Basic EPS	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	1.95 -70.5%	8.43 332.3%	3.37 -60.0%	10.77 219.6%	10.27 -4.6%	6.67 -35.1%	3.47 -48.0%	-0.33 -	-0.84 -	-1.83 -	-3.38 -	0.68 -
Diluted EPS	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	1.95 -70.5%	8.43 332.3%	3.37 -60.0%	10.77 219.6%	10.27 -4.6%	6.67 -35.1%	3.47 -48.0%	-0.33 -	-0.84 -	-1.83 -	-3.38 -	0.68 -